These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 18006623

  • 1. Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
    Kasama S, Toyama T, Sumino H, Matsumoto N, Sato Y, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M.
    J Nucl Med; 2007 Dec; 48(12):1993-2000. PubMed ID: 18006623
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
    Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M.
    J Nucl Med; 2003 Jun; 44(6):884-90. PubMed ID: 12791814
    [Abstract] [Full Text] [Related]

  • 8. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure.
    Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M.
    J Nucl Med; 2002 Oct; 43(10):1279-85. PubMed ID: 12368364
    [Abstract] [Full Text] [Related]

  • 9. Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril.
    Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M.
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):964-71. PubMed ID: 15803314
    [Abstract] [Full Text] [Related]

  • 10. Effects of spironolactone on cardiac sympathetic nerve activity and left ventricular remodelling after reperfusion therapy in patients with first ST-segment elevation myocardial infarction.
    Kasama S, Toyama T, Sumino H, Kumakura H, Takayama Y, Minami K, Ichikawa S, Matsumoto N, Sato Y, Kurabayashi M.
    Heart; 2011 May; 97(10):817-22. PubMed ID: 21378011
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
    Kasama S, Toyama T, Hatori T, Sumino H, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M.
    Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
    Kasama S, Toyama T, Kumakura H, Takayama Y, Ishikawa T, Ichikawa S, Suzuki T, Kurabayashi M.
    J Nucl Med; 2004 Jul; 45(7):1108-13. PubMed ID: 15235055
    [Abstract] [Full Text] [Related]

  • 14. Long-term nicorandil therapy improves cardiac sympathetic nerve activity after reperfusion therapy in patients with first acute myocardial infarction.
    Kasama S, Toyama T, Sumino H, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M.
    J Nucl Med; 2007 Oct; 48(10):1676-82. PubMed ID: 17873142
    [Abstract] [Full Text] [Related]

  • 15. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction.
    Kasama S, Toyama T, Hatori T, Sumino H, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M.
    J Am Coll Cardiol; 2007 Feb 13; 49(6):667-74. PubMed ID: 17291931
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S, Toyama T, Sumino H, Nakazawa M, Matsumoto N, Sato Y, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M.
    J Nucl Med; 2008 Jun 13; 49(6):907-14. PubMed ID: 18483106
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT, White M, Yan AT, Yusuf S, Rouleau JL, Maggioni AP, Hall C, Latini R, Afzal R, Floras J, Masson S, McKelvie RS, Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Investigators.
    Am J Cardiol; 2005 Sep 01; 96(5):698-704. PubMed ID: 16125499
    [Abstract] [Full Text] [Related]

  • 18. Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure.
    Chan AK, Sanderson JE, Wang T, Lam W, Yip G, Wang M, Lam YY, Zhang Y, Yeung L, Wu EB, Chan WW, Wong JT, So N, Yu CM.
    J Am Coll Cardiol; 2007 Aug 14; 50(7):591-6. PubMed ID: 17692742
    [Abstract] [Full Text] [Related]

  • 19. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW, Huang YW, Xia Q, Xu QW.
    Chin Med J (Engl); 2005 Jan 20; 118(2):146-54. PubMed ID: 15667801
    [Abstract] [Full Text] [Related]

  • 20. Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.
    White M, Rouleau JL, Afzal R, Floras J, Yusuf S, McKelvie RS.
    Ther Adv Cardiovasc Dis; 2009 Apr 20; 3(2):113-21. PubMed ID: 19299427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.